⌘K

Login Start Free

Home/Filings/4/0001208261-13-000018

4//SEC Filing

IMMUNE PHARMACEUTICALS INC 4

Accession 0001208261-13-000018

CIK 0001208261operating

View on SEC.gov Company Profile

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 5:13 PM ET

Size

7.6 KB

Accession

0001208261-13-000018

Insider Transaction Report

Form 4

Period: 2013-10-10

IMMUNE PHARMACEUTICALS INCIMNP

Director

Transactions

Award
Stock Option (right to buy)
2013-10-10+50,000→ 50,000 total
Exercise: $2.50From: 2013-10-10Exp: 2023-10-09→ Common stock, par value $0.0001 (50,000 underlying)
Award
Stock Option (right to buy)
2013-10-10+50,000→ 50,000 total
Exercise: $2.50Exp: 2023-10-09→ Common stock, par value $0.0001 (50,000 underlying)

Footnotes (3)

[F1]No consideration was given since option was granted pursuant to a stock option agreement.
[F2]Only represents the derivative securities of this class.
[F3]Shares vest quarterly over the next three years.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

IMMUNE PHARMACEUTICALS INC

CIK 0001208261

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001208261

Filing Metadata

Form type: 4
Filed: Oct 14, 8:00 PM ET
Accepted: Oct 15, 5:13 PM ET
Size: 7.6 KB

View on SEC.gov